SEC Tracker
Get the app

Cardiff Oncology CRDF

Cardiff Oncology appoints Dr. Mark Erlander to the board

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Cardiff Oncology files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Silence Therapeutics SLN public float $206M, Jun 30, 2025
  2. Rezolute RZLT public float $204M, Dec 31, 2025
  3. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025
  4. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  5. Rocket Pharmaceuticals RCKT public float $213M, Jun 30, 2025